Down-regulated microRNA-152 induces aberrant DNA methylation in hepatitis B virus-related hepatocellular carcinoma by targeting DNA methyltransferase 1
Top Cited Papers
- 15 March 2010
- journal article
- viral hepatitis
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Hepatology
- Vol. 52 (1), 60-70
- https://doi.org/10.1002/hep.23660
Abstract
The hepatitis B virus (HBV) X protein has been implicated as a potential trigger of the epigenetic modifications of some genes during hepatocarcinogenesis, but the underlying mechanisms remain unknown. MicroRNAs (miRNAs), which are noncoding RNAs that regulate gene expression, are involved in diverse biological functions and in carcinogenesis. In this study, we investigated whether some miRNAs are aberrantly expressed and involved in the regulation of the abnormal DNA methylation status in HBV‐related hepatocellular carcinoma (HCC). Our results showed that the expression of microRNA‐152 (miR‐152) was frequently down‐regulated in HBV‐related HCC tissues in comparison with adjacent noncancerous hepatic tissues and was inversely correlated to DNA methyltransferase 1 (DNMT1) messenger RNA (mRNA) expression in HBV‐related HCCs. The forced expression of miR‐152 in liver cell lines resulted in a marked reduction of the expression of DNMT1 at both the mRNA and protein levels by directly targeting the 3′ untranslated regions of DNMT1. This in turn led to a decrease in global DNA methylation, whereas inhibition of miR‐152 caused global DNA hypermethylation and increased the methylation levels of two tumor suppressor genes, glutathione S‐transferase pi 1 (GSTP1) and E‐cadherin 1 (CDH1). Conclusion: Our findings suggest that miR‐152 is frequently down‐regulated and regulates DNMT1 in HBV‐related HCC. These findings support a tumor‐suppressive role of miR‐152 in the epigenetic aberration of HBV‐related HCC and the potential development of miRNA‐based targeted approaches for the treatment of HBV‐related HCC. HEPATOLOGY 2010This publication has 42 references indexed in Scilit:
- Proteomic Profiling Identifies Aberrant Epigenetic Modifications Induced by Hepatitis B Virus X ProteinJournal of Proteome Research, 2008
- Chronic Hepatitis B — New Goals, New TreatmentThe New England Journal of Medicine, 2008
- Aberrant Epigenetic Modifications in Hepatocarcinogenesis Induced by Hepatitis B Virus X ProteinGastroenterology, 2007
- Alteration of DNA methyltransferases contributes to 5′CpG methylation and poor prognosis in lung cancerLung Cancer, 2007
- Genetic Disruption of Cytosine DNA Methyltransferase Enzymes Induces Chromosomal Instability in Human Cancer CellsCancer Research, 2005
- Primary liver cancer: Worldwide incidence and trendsGastroenterology, 2004
- HBsAg andHBx knocked into thep21 locus causes hepatocellular carcinoma in miceJournal of Hepatology, 2004
- Estimating the world cancer burden: Globocan 2000International Journal of Cancer, 2001
- Expression of DNA methyltransferases DNMT1,3A, and 3B in normal hematopoiesis and in acute and chronic myelogenous leukemiaBlood, 2001
- HBx gene of hepatitis B virus induces liver cancer in transgenic miceNature, 1991